T. Waldmann
Immunology · Proceedings of the National Academy of Sciences of the United States of America · 2002–2015
A researcher in the Science corpus: 9 papers; trusts 3 researchers and is trusted by 11 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 50 citations into it; #333 of 2,160 by trust here, #650 by citations
- Oncology — 20 citations into it
- Molecular Biology — 19 citations into it
Whom T. Waldmann trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts T. Waldmann overall
- P. Carter
- K. Palucka
- O. Boyman
- Jacques Banchereau
- Witold Lasek
- Amy T. Y. Yeung
- S. Rose‐John
- R. Bazak
- J. Sprent
Papers from T. Waldmann's perspective
Ordered by how strongly the researchers T. Waldmann trusts endorse each paper. Same corpus, a different order for every researcher.
- The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design (Nature reviews. Immunology)
- IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells (Proceedings of the National Academy of Sciences of the United States of America)
- Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function (Journal of Experimental Medicine)
- CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia (Science Translational Medicine)
- IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. (Blood)
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia (New England Journal of Medicine)
- SPICE: Exploration and Analysis of Post-Cytometric Complex Multivariate Datasets (Cytometry Part A)
- Frequent mutation of histone modifying genes in non-Hodgkin lymphoma (Nature)
- Roles of heat-shock proteins in innate and adaptive immunity (Nature reviews. Immunology)
- Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice (Journal of Experimental Medicine)
Their papers
- Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer. (2015) — 649 citations
- Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics (2012) — 975 citations
- The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design (2006) — 1,171 citations
- Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. (2006) — 625 citations
- Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. (2005) — 1,032 citations
- IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells (2004) — 619 citations
- IL-15/IL-15Rα-mediated avidity maturation of memory CD8 + T cells (2004) — 130 citations
- Immunotherapy: past, present and future (2003) — 628 citations
- IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells (2002) — 874 citations